09.12.2009 • Topics

Lonza to Build Cell Therapy Facility in Singapor

Swiss drugs industry supplier Lonza Group said it was building a new facility in Singapore to expand its cell therapy business. Lonza said that the total investment for the first phase would be approximately 30 million Swiss francs ($27.03 million). Construction is due to begin in early 2010 and the facility is expected to be operational by mid-2011, it added. "The facility will operate with cutting-edge technologies and a skilled labor force, allowing it to readily meet the needs of a broad range of customers and address the growing global demand for Cell Therapies," said Lonza CEO Stefan Borgas in a statement.

Interview

Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.